| NCT00526240 |
A Pilot Study of Tumor Vaccination in Patients With Neuroblastoma and Pediatric Sarcomas and Altered T-Cell Homeostasis |
National Cancer Institute |
| NCT00058799 |
Phase I CD40 Ligand & IL-2 gene modified leukemia vaccine |
Baylor College of Medicine |
| NCT00048386 |
Phase I/II IL-2 gene modified autologous neuroblastoma vaccine |
Baylor College of Medicine |
| NCT00703222 |
Phase I/II post autologous HSCT |
Baylor College of Medicine |
| NCT00002748 |
Phase I IL-2 gene modified autologous or partially matched allogeneic neuroblastoma vaccine |
St. Jude Children's Research Hospital |
| NCT00186862 |
Phase I Lymphotactin and IL-2 gene modified neuroblastoma vaccine post chemotherapy |
St. Jude Children's Research Hospital |
| NCT00258687 |
Phase I Vaccination with GM-CSF gene modified, autologous, lethally irradiated clear cell sarcoma, alveolar soft part sarcoma, renal cell carcinoma or melanoma vaccine |
Dana-Farber Cancer Institute |
| NCT00069940 |
Phase I Vaccination with telomerase peptide + GM-CSF for brain tumors, GIST and sarcomas |
Dana-Farber Cancer Institute |
| NCT00085397 |
Randomized Phase II Immunization against melanoma comparing autologous dendritic cells pulsed with gp100 peptide to autologous dendritic cells fused with autologous tumor cells |
Dana-Farber Cancer Institute |
| NCT00576641 |
Phase l Tumor-associated antigen pulsed dendritic cell vaccine for brain stem glioma and glioblastoma |
Cedars-Sinai Medical Center |
| NCT00576537 |
Phase ll Tumor lysate-pulsed dendritic cell vaccine for brain tumors |
Cedars-Sinai Medical Center |
| NCT00101309 |
Phase I EBV-transformed fusion tumor cell vaccine for relapsed Ewing's sarcoma and neuroblastoma |
Milton S. Hershey Medical Center |
| NCT00107185 |
Phase I Dose escalation study of autologous tumor lysate-pulsed dendritic cell vaccine for malignant gliomas |
Jonsson Comprehensive Cancer Center |
| NCT00405327 |
Phase II Tumor lysate-pulsed dendritic cell vaccine for high-risk solid tumor patients following autologous HSCT |
University of Michigan Cancer Center |
